Heart failure is a serious and widespread health condition that affects millions of people in the United States and many more around the world. It places a heavy burden on both patients and healthcare systems because it often requires long-term treatment, frequent medical visits, and sometimes hospital care.
Heart failure does not mean that the heart has completely stopped working. Instead, it means that the heart is not able to pump blood effectively enough to meet the body’s needs.
When the heart cannot move blood properly through the body, many symptoms may appear. People with heart failure often feel very tired because their muscles and organs are not receiving enough oxygen-rich blood.
Shortness of breath is also common, especially during physical activity or when lying down. Another typical sign is swelling in the legs, ankles, or abdomen. This swelling happens when fluid builds up in the body because the heart is struggling to circulate blood efficiently.
In many cases, heart failure occurs when the heart muscle becomes weak and loses its ability to pump blood with enough force. Doctors call this condition heart failure with reduced ejection fraction.
Treatments for this type of heart failure have improved over the years, and several medications are known to help patients live longer and avoid hospitalization.
However, about half of all heart failure patients have a different form of the disease. In these cases, the heart muscle still pumps normally, but it becomes stiff and cannot relax properly between beats.
Because the heart cannot relax well, it cannot fill with enough blood before pumping again. This condition is known as heart failure with preserved ejection fraction, often shortened to HFpEF. Many people also refer to it as “stiff heart” heart failure.
This form of heart failure is especially common in older adults and appears more often in women. It is also closely linked with other health problems such as high blood pressure, diabetes, obesity, and aging-related changes in the heart and blood vessels. Unfortunately, doctors still have limited treatment options for this condition, and managing it can be challenging.
A new study from researchers at the University of Vermont has raised important questions about one of the most widely used types of heart medication. The study examined beta-blockers, a group of drugs that have been used for many years to treat heart disease.
Beta-blockers work by slowing the heart rate and lowering blood pressure. By doing this, they reduce the workload placed on the heart.
For patients whose hearts are weak and cannot pump effectively, beta-blockers are known to be very helpful. They can reduce symptoms, prevent hospital visits, and improve survival in patients with reduced pumping function.
However, scientists are less certain about how these medications affect patients with stiff heart failure. Because the pumping ability of the heart is still normal in these patients, the main problem is not the strength of the heartbeat but the heart’s ability to relax and fill with blood.
To investigate whether beta-blockers are beneficial or harmful in these cases, researchers analyzed data from a large clinical trial called TOPCAT. This study included patients diagnosed with heart failure with preserved ejection fraction. Among the participants in the trial, around 80 percent were taking beta-blockers.
The research team, led by Dr. Timothy Plante, carefully compared outcomes between people who were using beta-blockers and those who were not. Their analysis produced a surprising result. Patients taking beta-blockers had a 74 percent higher risk of being hospitalized for heart failure compared with those who were not using the medication.
The researchers believe this may happen because slowing the heart rate could worsen the filling problem in stiff heart failure.
When the heart muscle is already struggling to relax, reducing the heart rate may cause pressure to increase inside the heart and lungs. This pressure can lead to fluid buildup, making breathing more difficult and increasing the likelihood of hospitalization.
These findings are particularly important because beta-blockers are frequently prescribed to many heart patients. In some cases, they may be given automatically to people with heart failure without fully considering the differences between various types of the disease.
The study suggests that heart failure should not be treated as a single condition with one universal treatment. Two patients may have similar symptoms but very different underlying problems in their hearts. Because of this, treatments that help one group of patients may not help another and could potentially cause harm.
Researchers and doctors agree that more studies are needed to better understand how medications affect people with stiff heart failure. At the moment, there are still relatively few proven treatments for this form of the disease, and many treatment decisions rely on clinical experience rather than strong scientific evidence.
This research highlights the growing need for more personalized medical care. By carefully studying how different treatments affect specific types of heart failure, doctors may eventually develop better strategies to help patients manage their symptoms and improve their quality of life.
For more information about health, please see recent studies that Vitamin D deficiency can increase heart disease risk, and results showing Zinc and vitamin B6 linked to lower death risk in heart disease.
For more information about heart health, please see recent studies about more coffee linked to heart rhythm disease, and results showing Zinc and vitamin B6 linked to lower death risk in heart disease.
The research findings were published in JAMA Network Open.
Copyright © 2026 Knowridge Science Report. All rights reserved.
